Showing results (531-540 of 977) with videos related to
Sort By:
Pageof 98
NPJ Breast Cancer|February 13, 2020
Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patientsNadine Norton, Bahaaeldin Youssef, David W Hillman, et al.NPJ Breast Cancer|December 17, 2019
Androgen receptor gene expression in primary breast cancerNeelima Vidula, Christina Yau, Denise Wolf, et al.NPJ Breast Cancer|September 5, 2020
Breast cancer gene expression datasets do not reflect the disease at the population levelYanping Xie, Brittny C Davis Lynn, Nicholas Moir, et al.NPJ Breast Cancer|September 23, 2020
Cyclin E expression is associated with high levels of replication stress in triple-negative breast cancerSergi Guerrero Llobet, Bert van der Vegt, Evelien Jongeneel, et al.NPJ Breast Cancer|September 23, 2020
Incorporation of biologic factors for the staging of de novo stage IV breast cancerZhen-Yu He, Chen-Lu Lian, Jun Wang, et al.NPJ Breast Cancer|March 29, 2020
Incorporation of clinical and biological factors improves prognostication and reflects contemporary clinical practiceRashmi K Murthy, Juhee Song, Akshara S Raghavendra, et al.NPJ Breast Cancer|January 25, 2019
MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancerStephen Johnston, Miguel Martin, Angelo Di Leo, et al.NPJ Breast Cancer|January 25, 2019
Assessment of HMGA2 and PLAG1 rearrangements in breast adenomyoepitheliomasFresia Pareja, Felipe C Geyer, David N Brown, et al.NPJ Breast Cancer|December 10, 2020
Predicting breast cancer response to neoadjuvant treatment using multi-feature MRI: results from the I-SPY 2 TRIALWen Li, David C Newitt, Jessica Gibbs, et al.NPJ Breast Cancer|September 6, 2022
STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in BRCA-associated breast cancerConstantia Pantelidou, Heta Jadhav, Aditi Kothari, et al.Pageof 98